“…These findings differ from prior reports, which found a higher frequency of SCH in patients who were pregnant after in vitro fertilization than those conceived naturally. 21,22 In our study, the rate of pregnancy loss was significantly higher in patients 35 years or older with an SCH than those younger than 35 years, a finding consistent with at least 1 prior study. 9 One limitation of our study was that we were not able to collect information on other factors that may influence the pregnancy loss rate, such as parity, maternal comorbidities, and a history of pregnancy loss.…”
Section: Discussionsupporting
confidence: 92%
“…What we also found was that the presence of vaginal bleeding had no impact on the rate of pregnancy loss, nor did a history of pregnancy achieved by assisted reproductive techniques. These findings differ from prior reports, which found a higher frequency of SCH in patients who were pregnant after in vitro fertilization than those conceived naturally . In our study, the rate of pregnancy loss was significantly higher in patients 35 years or older with an SCH than those younger than 35 years, a finding consistent with at least 1 prior study .…”
Subjective hematoma size based on the fraction of gestational sac size correlates best with first-trimester pregnancy outcome. The earlier in pregnancy an SCH is detected, the higher the rate of subsequent pregnancy failure.
“…These findings differ from prior reports, which found a higher frequency of SCH in patients who were pregnant after in vitro fertilization than those conceived naturally. 21,22 In our study, the rate of pregnancy loss was significantly higher in patients 35 years or older with an SCH than those younger than 35 years, a finding consistent with at least 1 prior study. 9 One limitation of our study was that we were not able to collect information on other factors that may influence the pregnancy loss rate, such as parity, maternal comorbidities, and a history of pregnancy loss.…”
Section: Discussionsupporting
confidence: 92%
“…What we also found was that the presence of vaginal bleeding had no impact on the rate of pregnancy loss, nor did a history of pregnancy achieved by assisted reproductive techniques. These findings differ from prior reports, which found a higher frequency of SCH in patients who were pregnant after in vitro fertilization than those conceived naturally . In our study, the rate of pregnancy loss was significantly higher in patients 35 years or older with an SCH than those younger than 35 years, a finding consistent with at least 1 prior study .…”
Subjective hematoma size based on the fraction of gestational sac size correlates best with first-trimester pregnancy outcome. The earlier in pregnancy an SCH is detected, the higher the rate of subsequent pregnancy failure.
“…The inconsistencies may result from differences in the resolution of the ultrasonographic instruments or study populations. One study suggested that subchorionic hematoma occurs more frequently in pregnancies after IVF compared with spontaneous conception (18), but the mechanism underlying this finding is still unclear.…”
The discriminant forecasting models are accurate in predicting first trimester pregnancy outcomes based on the first scan for early pregnancy after ET. When the predictive result is ongoing pregnancy, a second scan can be postponed until 11-14 weeks if no symptoms of abdominal pain or vaginal bleeding are present. When the predictive results suggest early pregnancy loss, repeated scans are imperative to avoid a misdiagnosis before evacuating the uterus.
“…[8][9][10] Moreover, a higher incidence of SCH in pregnancy achieved by assisted reproductive technology (ART) than in spontaneous pregnancy has been reported. 11 Therefore, the association of SCH in early pregnancy with ART-related pregnancy complications is an interesting topic.…”
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.